2022
DOI: 10.21926/obm.icm.2203026
|View full text |Cite
|
Sign up to set email alerts
|

Improving Tolerance and Compliance of New Targeted Therapies with Homeopathy: A Major Challenge in Oncology

Abstract: The application of targeted therapies (TT) in oncology has prolonged survivals and even enabled complete remission of cancers previously considered incurable. With small therapeutic indices, the reduction in dosage or spacing out of the doses of TT due to side effects, represents a significant loss of treatment opportunity for the patients. In the absence of drug interaction and significant side effects, homeopathy used in supportive care improves the quality of life of patients, compliance with oncological tr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 26 publications
0
1
0
Order By: Relevance
“…We explain to her again the reasons for the adjuvant chemotherapy to come, the potential side effects, in particular the risk of peripheral neuropathy due to oxaliplatin, fatigue and nausea. We give her lifestyle medicine advice to facilitate tolerance to chemotherapy, both physically and emotionally, and prescribe supportive care homeopathic treatment according to the therapeutic regimen that we regularly apply in these cases 14 ( Fig. 1 ).…”
Section: Clinical Casementioning
confidence: 99%
“…We explain to her again the reasons for the adjuvant chemotherapy to come, the potential side effects, in particular the risk of peripheral neuropathy due to oxaliplatin, fatigue and nausea. We give her lifestyle medicine advice to facilitate tolerance to chemotherapy, both physically and emotionally, and prescribe supportive care homeopathic treatment according to the therapeutic regimen that we regularly apply in these cases 14 ( Fig. 1 ).…”
Section: Clinical Casementioning
confidence: 99%